What Patients Using a Compounded GLP-1 Should Do Now No one should stop a medication abruptly based on a regulatory news story, and that caution applies with particular force to anyone using a GLP-1 for diabetes
Physician assessment (45-60 minutes) Detailed discussion of your health history and goals Review of symptoms youre experiencing Physical assessment if relevant to your concerns Explanation of how peptides could address your specific needs 3
The confirmation hearing was delayed but is set to happen this week
Decisions regarding therapy resumption should involve a careful risk-benefit discussion with a qualified healthcare professional
Novo Nordisk Sues Florida Compounding Pharmacies Over Semaglutide Impurities As Novo Nordisk, the Danish manufacturer of Ozempic, struggles to meet the global demand for its blockbuster drug, compounding pharmacies have stepped in to address the supply shortage
Its not about willpower, it's about science backed results Ozempic is FDA-approved for type 2 diabetes, improving glycemic control, helping control hunger and cravings